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Abstract
Background: Pancreatitis is a serious complication after cardiac surgery and can lead to significant morbidities and
mortality. The incidence of pancreatitis is even higher in patients undergoing heart transplantation than in those
undergoing other cardiac surgeries. Nevertheless, the clinical presentations of pancreatitis are frequently atypical in
these patients.
Case presentation: We report a heart recipient who was complicated with acute right heart failure initially after
orthotopic heart transplantation and developed devastating unanticipated hemorrhagic pancreatitis 1 month after
the transplantation. This crypto-symptomatic pancreatitis was not diagnosed until massive internal bleeding and
hemorrhagic shock occurred, because the typical presentations of acute pancreatitis were masked by the intra-
abdominal manifestations caused by right heart failure and congestive liver dysfunction. The patient underwent a
successful transarterial embolization.
Conclusions: The causes of pancreatitis after heart transplantation include low cardiac output, immunosuppressant
use and cytomegalovirus infection. The typical symptoms of pancreatitis might be not apparent in patients after
heart transplantation because of their immunosuppressive status. Furthermore, in patients complicated with right
heart failure after transplantation, the manifestation of pancreatitis could be even more obscure. The prompt
diagnosis is highly depended on the clinician’s astuteness.
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Background
Pancreatitis is one of the most serious gastrointestinal
complications after cardiac surgery that requires a
cardiopulmonary bypass, e.g., a heart transplantation
[1–3]. Although some risk factors have been identi-
fied, the association between post-transplantation
acute right heart failure and pancreatitis has rarely
been discussed. In such cases, acute pancreatitis
might be overlooked because its characteristic
symptoms can be concealed by the intra-abdominal
presentations caused by right heart failure and subse-
quent congestive liver dysfunction.
Case presentation
A 43-year-old man with non-ischemic dilated
cardiomyopathy-related end-stage heart failure under-
went orthotopic heart transplantation. Before surgery, he
has a fluctuated heart function which was dependent on
mid-level dose of intravenous inotropes (~5 μg/kg/min
dobutamine) and his Interagency Registry for Mechanic-
ally Assisted Circulatory Support (INTERMACS) profile
was level 3. His preoperative serum creatinine level was
2.3 mg/dL and estimated glomerular filtration rate
(eGFR) was 33 ml/min/1.73 m2. His serum total
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bilirubin had risen to 3.2 mg/dL; and his Child-
Turcotte-Pugh and Model for End-Stage Liver Disease
(MELD) scores were 8 and 23 points, respectively. A
right heart hemodynamic study before transplantation
revealed that the transpulmonary pressure gradient
(TPG) was 11 mmHg and the pulmonary vascular resist-
ance (PVR) was 3.63 Wood units. Moreover, the body
weight of the male donor was only 80% of the patient’s.
Right heart failure developed on postoperative day 2 and
the patient had an extremely high central venous pres-
sure (CVP) level (27 mmHg), abundant ascites, and
acute kidney injury that required continuous renal
replacement therapy. A fulminant hepatic failure also
developed and his serum total bilirubin peaked at
23 mg/dL in the first weeks after his heart transplant-
ation. Abdominal echography excluded biliary tract ob-
struction and cholelithiasis. Plasmapheresis was done
three times because of the patient’s progressive hyperbi-
lirubinemia. Four weeks after the transplantation, his
condition stabilized; nevertheless, on postoperative day
31, the patient manifested painful diffuse abdominal dis-
tention associated with hypovolemic shock and a
decrease in blood hematocrit level (Fig. 1). Contrast-
enhanced abdominal computed tomography (CT)
showed a heterogeneous pattern of the pancreas and
one huge retroperitoneal hematoma with active bleeding
in the left pararenal region (Fig. 2a, b and c). Although
the serum amylase and lipase levels were both within
the normal range at that time, a prior acute pancreatitis
episode with subsequent enzymatic destruction of adja-
cent vasculatures, i.e., hemorrhagic pancreatitis, was
suspected. An emergency transarterial embolization
(TAE) was done for the actively bleeding left ante-
roinferior subsegmental renal artery with several pled-
gets of gelatin sponge (Gelfoam, Pfizer, New York,
N.Y.). After bleeding ceased, a conservative treatment
strategy for pancreatitis was adopted for this patient
since no other complication occurred. Two months
later, a second abdominal CT showed calcification of
and adjacent fluid accumulation in the pancreas
(Fig. 2d), and external drainage of the fluid revealed
high amylase and lipase levels (1037 U/L and 4035
U/L, respectively), both of which were compatible
with chronic pancreatitis with a pseudocyst. An exter-
nal drain was kept in situ for an additional 2 months.
The patient was discharged from the hospital 6
months after his heart transplantation; at that time,
the patient’s right heart function had improved: CVP
was ca. 6 mmHg, eGFR was ca. 60 ml/min/1.73 m2,
and he had no more hyperbilirubinemia.
Conclusions
The incidence of pancreatitis in patients who have under-
gone orthotopic heart transplantation ranges from 2 to
18%, which is 15 to 25 times higher than after other cardiac
procedures and causes high mortality [1–3] Nevertheless,
a diagnosis of pancreatitis after heart transplantation
might be difficult and often delayed because of its ob-
scured clinical presentation [1]. Immunosuppressive status
after transplantation conceals the systemic inflammatory
response and contributes to so-called crypto-symptomatic
pancreatitis [3]. Some immunosuppressants, such as cor-
ticosteroid, azathioprine, cyclosporine, and (rarely)
tacrolimus, are known to be associated with pancreatitis
[2, 3]; however, drug-related pancreatitis was not likely in
this patient because he eventually recovered without
stopping any of these medications. Cytomegalovirus
infection is proposed to be another important eti-
ology of pancreatitis in patients who have undergone
a transplantation [2, 3], but this was excluded by the
patient’s negative antigenemia. Low cardiac output
after cardiac surgery is known to be a risk factor for
developing postoperative pancreatic cell injury [4].
Decompensated liver failure is also frequently associ-
ated with acute pancreatitis: the incidence in more
than 30% [5]. Hence, pancreatitis in patients with
acute right heart failure is reasonably contributed by
a right-side pumping failure-related low cardiac out-
put and congestive hepatic dysfunction. However, in
patients who develop right heart failure after a heart
transplantation, clinical recognition of pancreatitis could
be even more difficult, not only because of the suppressed
inflammatory response, but also because the typical
Fig. 1 Postoperative series change of inotropes dose, central venous
pressure (CVP), and hematocrit (Hct). The initial high dose of
inotropes was necessary for acute right heart failure. Shock with
decreased CVP and Hct on postoperative day 31 was caused by
active retroperitoneal bleeding; the patient was stabilized after an
emergency transarterial embolization. The inotropes equivalent was
defined as the dose of dopamine + dose of dobutamine + dose of
epinephrine × 100 + dose of norepinephrine × 100 (μg/kg/min)
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presentations of acute pancreatitis are masked by the
intra-abdominal manifestations caused by right heart fail-
ure and hepatic dysfunction, such as abundant ascites, im-
paired digestion, and abdominal tenderness, as in our
patient. In the presented case, the diagnosis of pancreatitis
was not established until massive internal bleeding and
hemorrhagic shock occurred. A high index of suspicion,
regular monitoring of serum pancreatic enzymes, and
more liberal use of abdominal CT or magnetic reson-
ance imaging are recommended to identify this
undesired complication for patients who develop right
heart failure after a heart transplantation. Finally,
utility of mechanical circulatory supports, i.e., extra-
corporeal membrane oxygenation (ECMO) or ven-
tricular assist devices (VADs), should be advocated in
the early postoperative phase in the presented case
developing considerable postoperative right heart fail-
ure, to avoid subsequent multiorgan dysfunction and
the devastating hemorrhagic pancreatitis.
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Fig. 2 a An axial view of the contrast-enhanced abdominal CT shows in the pancreas a heterogeneous pattern and some calcified spots (arrowhead)
that are compatible with pancreatitis. b A coronal view shows intrapancreatic calcifications (arrowheads) and one high dense lesion, with a huge
hematoma, which occupied the perisplenic and pararenal retroperitoneal space and extended to the lower left abdomen (asterisk). c A high-resolution
image shows one active contrast medium extravasation in the pararenal region (arrow). There was also abundant ascites, caused by advanced hepatic
failure and right heart failure. d A coronal view of contrast-enhanced abdominal CT 2 months later showed fluid accumulated in the space previously
occupied by the hematoma (asterisk), which is compatible with chronic pancreatitis with one huge and extended pseudocyst, because the fluid had
an extremely high concentration of pancreatic enzymes
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